AMA Opposes Proposed Cuts, Gag Orders for Reproductive Health

Share this content:
AMA Opposes Proposed Cuts, Gag Orders for Reproductive Health
AMA Opposes Proposed Cuts, Gag Orders for Reproductive Health

MONDAY, July 30, 2018 (HealthDay News) -- The American Medical Association (AMA) strongly objects to the Trump administration's plan to withhold federal family planning funding from Planned Parenthood and other entities, according to a statement released by the organization.

The AMA says the cuts would impact the Title X program, which ensures that uninsured and low-income patients have access to basic, preventive reproductive health care, including birth control, cancer screenings, sexually transmitted infection testing and treatment, and exams. This national program serves four million people each year.

"High-quality medical care relies on honest, unfiltered conversations between patients and their physicians," David Barbe, M.D., immediate past president of the AMA, said in a statement. "Gag orders that restrict the ability of physicians to explain all options to their patients and refer them -- whatever their health care needs -- compromise this relationship and force physicians and nurses to withhold information that their patients need to make decisions about their care."

The U.S. Department of Health and Human Services is accepting comments on the proposed regulations through July 31.

AMA Statement
AMA Wire Article
Comment on Regulations

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »